Merck

Merck & Co., Inc. is a biopharmaceutical company headquartered in Kenilworth, New Jersey, that specializes in developing and delivering medicines and vaccines for a variety of diseases. Established in 1891, the company is committed to discovering innovative products and services that enhance and save lives globally. Merck operates through various divisions, including Merck Research Laboratories, which focuses on developing treatments for cancer and neurodegenerative disorders. Additionally, Merck has investment arms such as the Merck Global Health Innovation Fund and Merck Capital Ventures, which invest in emerging healthcare technology companies and services. These funds support innovations in digital health, diagnostics, and patient engagement, aiming to leverage data to enhance healthcare solutions. Merck's extensive portfolio includes not only pharmaceuticals and vaccines but also consumer and animal health products, making it a significant player in the global healthcare landscape.

Alexis Constantine

Senior Specialist, Investor Relations

Peter Dannenbaum

Vice President, Investor Relations

Robert M. Davis

Executive Vice President, Global Services and Chief Financial Officer

Michael DeCarbo

Executive Director, Investor Relations

Carol Ferguson

Executive Director and Business Development

Kenneth Frazier

Chairman and Chief Executive Officer

Amy Klug

Executive Director, Investor Relations

Joel Krikston

Managing Director

Teri Loxam

Senior Vice President, Investor Relations and Global Communications

Courtney Ronaldo

Director, Investor Relations

David Rubin

Managing Director

Dave Stevenson

Managing Director

Bill Taranto

President

Prem Tumkosit

Managing Director

Joe Volpe

Managing Director

Past deals in Health Care

Qure AI

Series C in 2022
At Qure.ai their mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients.

CancerIQ

Series B in 2022
CancerIQ’s technology enables hospitals to identify, evaluate and manage entire patient populations based on individual genetic risk factors. By analyzing family history, running predictive risk models and automating NCCN guidelines, CancerIQ empowers community-based providers with the genetic expertise to prevent cancer or catch it early. The platform has been rapidly adopted by some of the top health systems in the country and fully integrates with genetics laboratories, EHRs, and specialty software vendors to streamline workflow, guide clinician decision making, achieve cost savings, and – most importantly – improve patient outcomes. Learn more about how CancerIQ is scaling the use of genetic testing to predict, preempt and prevent disease at canceriq.com.

Koneksa Health

Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company based in New York, with an additional location in London. Founded in 2013, the company specializes in designing and developing software for pharmaceutical and biotech firms to facilitate decision-making and regulatory claims based on remotely generated patient data. Its flagship product, Koneksa Compare, provides a dashboard for capturing, monitoring, and analyzing patient-generated data and outcomes in clinical studies. The software supports the integration of emerging technologies, such as bio-sensors, activity trackers, and mobile-based questionnaires, allowing researchers to expand the range of analyzable data and reduce subjectivity in clinical endpoints. Koneksa Health aims to enhance the efficiency and accuracy of clinical research through its innovative solutions.

Verana Health

Series E in 2022
Innovation in healthcare is hindered by the time and cost of bringing new products to market. Verana Health is partnering with medical associations to build a regulatory-grade data platform for health care innovation that utilizes specialty clinical data sets. Verana Health’s platform enables physicians and industry to work together towards their shared goal of accelerating the availability of better treatments and cures for patients. Learn more at veranahealth.com.

Transcarent

Series C in 2022
Transcarent is a consumer digital health company, uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions. We believe that having the right information, tools, and incentives in the decision-making process can be positively transformative in the way we all experience healthcare.

Strata Oncology

Series C in 2021
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

Transcarent

Series B in 2021
Transcarent is a consumer digital health company, uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions. We believe that having the right information, tools, and incentives in the decision-making process can be positively transformative in the way we all experience healthcare.

Koneksa Health

Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company based in New York, with an additional location in London. Founded in 2013, the company specializes in designing and developing software for pharmaceutical and biotech firms to facilitate decision-making and regulatory claims based on remotely generated patient data. Its flagship product, Koneksa Compare, provides a dashboard for capturing, monitoring, and analyzing patient-generated data and outcomes in clinical studies. The software supports the integration of emerging technologies, such as bio-sensors, activity trackers, and mobile-based questionnaires, allowing researchers to expand the range of analyzable data and reduce subjectivity in clinical endpoints. Koneksa Health aims to enhance the efficiency and accuracy of clinical research through its innovative solutions.

Preventice Solutions

Series B in 2020
Preventice Solutions, Inc. is a provider of healthcare solutions specializing in mobile health technologies and services. Founded in 2007 and based in Eagan, Minnesota, the company offers a range of platforms, including the PatientCare Portal for real-time patient data management, the PatientView Portal for healthcare organizations, and the PatientFlow Portal for monitoring centers. Preventice is known for its advanced wearable monitoring devices, such as the BodyGuardian Heart, which enhances patient mobility and compliance, and the BodyGuardian Verité, a dual-modality cardiac sensor. These technologies aim to facilitate the monitoring and management of patients with cardiac issues, improving health outcomes while potentially reducing the cost of care. The company was formed through the merger of Preventice Services and Preventice Technologies in 2014, and it operates additional offices in Fargo, North Dakota, San Francisco, California, and Houston, Texas.

Syapse

Series F in 2020
Syapse, Inc. is a company that specializes in precision medicine through its software platform, which integrates and analyzes clinical, molecular, treatment, and outcomes data. This platform supports data-driven decision-making for healthcare executives, care teams, and researchers involved in precision medicine programs. One of its key offerings is the Syapse Learning Health Network, a global data-sharing network focused on oncology, which leverages real-world data to enhance clinical decision-making. By connecting health systems, life sciences companies, and regulators, Syapse aims to accelerate the generation of real-world evidence to improve cancer patient outcomes. Founded in 2008 and headquartered in San Francisco, California, Syapse is committed to ensuring that all cancer patients receive high-quality care through improved precision medicine initiatives.

Ayogo Health

Series B in 2020
Ayogo Health Inc. develops games and applications for management of chronic health conditions and patient adherence. Its products include GoodLife, a customizable platform that uses tailor-made gamification components, incentives, and social features; and Alternate Reality Games, a suite of learning applications which combines online and real-world elements. The company was founded in 2008 and is based in Vancouver, Canada.

She's Well

Seed Round in 2019
She’s Well brings a Netflix-like subscription model to fertility, to help women, men, and couples to have children when they’re ready. The company works with its network of top-tier fertility centers to provide financing plans for fertility testing, IVF, egg freezing and sperm freezing. With an on-demand concierge care approach, She’s Well provides support and guidance, to make the fertility journey less confusing and isolating. 1 in 6 couples has trouble conceiving and we’re waiting longer to try. Women increasingly delay childbirth - one in three women in the U.S. has her first child after 30 and one in ten after 35. Male sperm count has decreased over 50 percent in the last decade. Despite all the solutions available on the market, infertility services remain available to only 1%. Health plans usually don't cover infertility treatments. The typical costs range from 12,000 to 20,000 dollars for IVF, plus another few thousand for the genetic testing involved to ensure the fetus is chromosomally normal. To help, She’s well started out offering subscription plans and concierge guidance to make fertility care more affordable and accessible to the 99%. We need to usher a world where decisions about family and career aren't ruled by biological clocks and where the best options, science, and care are available to everyone who wants to start a family.

CIOX

Private Equity Round in 2019
CIOX Health, LLC is a healthcare services company based in Alpharetta, Georgia, specializing in the management and exchange of health information. The firm operates a cloud-based platform that digitizes and organizes both structured and unstructured medical records, facilitating access to clinical data for various stakeholders, including healthcare providers, health plans, and government agencies. CIOX offers a range of services including information release, medical record retrieval, coding and education, and risk adjustment solutions. Their expertise is designed to improve patient outcomes while ensuring compliance with regulations regarding the release of medical information. CIOX Health serves a diverse clientele, including hospitals, physician practices, law firms, and life insurance companies, making it a key player in the healthcare information management sector. The company was established in 1976 and operates additional locations in Phoenix, Arizona, and Green Bay, Wisconsin.

ConnectMed

Acquisition in 2019
ConnectedMed builds digital therapeutics platform that allows patients to manage their primary and chronic care needs.

Clinithink

Series B in 2019
Clinithink Ltd develops cloud based data analytics software for healthcare sector. Its product includes CLiX ENRICH, a platform which collects clinical trial data using structured tools and methodologies, records data in their preferred narrative style, and enables content indexing. It also offers CLiX RARE for diagnosing genetic disorders in newborns. The company serves healthcare providers, pharmaceutical companies, and content vendors. Clinithink Ltd was founded in 2009 and is based in Bridgend, United Kingdom.

ClearDATA

Series E in 2018
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Strata Oncology

Series B in 2018
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

Prognos

Series C in 2017
Prognos is a healthcare AI company dedicated to improving disease management through early intervention in collaboration with payers, life sciences, and diagnostics companies. It operates the Prognos Registry, which is the largest repository of clinical diagnostics information, encompassing over 5 billion medical records across more than 30 disease areas and covering 100 million patients. The company has developed 500 proprietary clinical algorithms that facilitate the early identification of patients, thereby enhancing treatment decision-making and risk management. Its platform, prognosFACTOR, efficiently analyzes vast amounts of lab and health records from over 325 million de-identified patients, providing rapid answers to clinically-focused healthcare inquiries. Prognos offers HIPAA-compliant healthcare data through its Prognos Marketplace, catering to various applications such as cohort design and health outcomes analysis, with a client base that includes a significant number of leading pharmaceutical manufacturers and payers.

Syapse

Series D in 2017
Syapse, Inc. is a company that specializes in precision medicine through its software platform, which integrates and analyzes clinical, molecular, treatment, and outcomes data. This platform supports data-driven decision-making for healthcare executives, care teams, and researchers involved in precision medicine programs. One of its key offerings is the Syapse Learning Health Network, a global data-sharing network focused on oncology, which leverages real-world data to enhance clinical decision-making. By connecting health systems, life sciences companies, and regulators, Syapse aims to accelerate the generation of real-world evidence to improve cancer patient outcomes. Founded in 2008 and headquartered in San Francisco, California, Syapse is committed to ensuring that all cancer patients receive high-quality care through improved precision medicine initiatives.

CareSync

Series B in 2017
CareSync is the leading provider of software and services for chronic disease management, combining technology with 24/7 nursing services to facilitate care coordination among patients, family and caregivers and all providers. CareSync provides turnkey Chronic Care Management services and a software-only option, allowing practices of any size to easily meet the billing requirements for CPT code 99490. Additionally, CareSync’s certified technology makes it simple for providers to meet Meaningful Use 2 for Data Exchange, Messaging, and Timely Access. CareSync patients are at the center of their healthcare, with access to health information, actionable goals, and Comprehensive Care Plan tasks, and as a result, are experiencing more productive medical appointments and better health outcomes.

ClearDATA

Series D in 2017
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Arcadia Solutions

Venture Round in 2017
Arcadia is a population health management company, specializing in data aggregation, analytics, and workflow software for value-based care. Its customers achieve financial success in their risk-sharing contracts through Arcadia’s focus on creating the highest quality data asset, pushing expertly derived insights to the point of care, and supporting administrative staff with data when and where they need it with applications including care management and referral management. Arcadia has off-the-shelf integration technology for more than 40 different physical and behavioral health EHR vendors, powered by machine learning that combs through variations in over 60 million longitudinal patient records across clinical, claims, and operational data sources.

StayWell Company

Acquisition in 2016
StayWell is a health engagement company that helps its clients engage and educate people to improve health and business results. We bring decades of experience working across the health care industry to design solutions that address our clients’ evolving needs. StayWell fuse expertise in health engagement and the science of behavior change with an integrated portfolio of solutions and robust content assets. Our customizable programs are proven to effectively engage people to make positive health care decisions—across even the most challenging populations. StayWell want you to know your programs are working—and see unmistakable benefits. A passion for data is at the heart of what we do and informs every stage of our work from program design to implementation to continual performance review. That’s why our clients across the health spectrum know us for results: diminished health costs, accelerated group participation, increased patient acquisition, better health outcomes and unprecedented program satisfaction.

medCPU

Venture Round in 2016
medCPU, Inc. delivers real-time clinical care advice through its Advisor Button technology for hospitals in the United States. Its Advisor Button captures the clinical picture from clinicians’ free-text notes, dictations, and structured documentation entered into EMR and analyzes it against a growing library of content for generating real-time precise prompts for care consideration; medCPU platform captures the clinical picture in real time, including narrative text and structured data to deliver the clinical and compliance guidance

CareSync

Series B in 2015
CareSync is the leading provider of software and services for chronic disease management, combining technology with 24/7 nursing services to facilitate care coordination among patients, family and caregivers and all providers. CareSync provides turnkey Chronic Care Management services and a software-only option, allowing practices of any size to easily meet the billing requirements for CPT code 99490. Additionally, CareSync’s certified technology makes it simple for providers to meet Meaningful Use 2 for Data Exchange, Messaging, and Timely Access. CareSync patients are at the center of their healthcare, with access to health information, actionable goals, and Comprehensive Care Plan tasks, and as a result, are experiencing more productive medical appointments and better health outcomes.

medCPU

Series B in 2015
medCPU, Inc. delivers real-time clinical care advice through its Advisor Button technology for hospitals in the United States. Its Advisor Button captures the clinical picture from clinicians’ free-text notes, dictations, and structured documentation entered into EMR and analyzes it against a growing library of content for generating real-time precise prompts for care consideration; medCPU platform captures the clinical picture in real time, including narrative text and structured data to deliver the clinical and compliance guidance

ClearDATA

Series C in 2015
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Koneksa Health

Funding Round in 2015
Koneksa Health Inc. is a healthcare data analytics company based in New York, with an additional location in London. Founded in 2013, the company specializes in designing and developing software for pharmaceutical and biotech firms to facilitate decision-making and regulatory claims based on remotely generated patient data. Its flagship product, Koneksa Compare, provides a dashboard for capturing, monitoring, and analyzing patient-generated data and outcomes in clinical studies. The software supports the integration of emerging technologies, such as bio-sensors, activity trackers, and mobile-based questionnaires, allowing researchers to expand the range of analyzable data and reduce subjectivity in clinical endpoints. Koneksa Health aims to enhance the efficiency and accuracy of clinical research through its innovative solutions.

Ayogo Health

Series A in 2015
Ayogo Health Inc. develops games and applications for management of chronic health conditions and patient adherence. Its products include GoodLife, a customizable platform that uses tailor-made gamification components, incentives, and social features; and Alternate Reality Games, a suite of learning applications which combines online and real-world elements. The company was founded in 2008 and is based in Vancouver, Canada.

Daktari Diagnostics

Series D in 2015
Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

WiserTogether

Series B in 2014
WiserTogether’s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in the outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers, and providers. The company serves over 3 million people through their employers and health plans. It was founded in 2008 and is based in Washington, District of Columbia.

Preventice

Acquisition in 2014
Preventice Inc. develops mobile health applications and patient monitoring systems that connect mobile, home-based, and on-premise technologies for continuous patient care. It offers HealthClips Rx, an interactive patient education platform that feeds data about patient compliance and post-surgical complications back into the clinical system; and CARD-Contact Allergen Replacement Database, which provides people with skin allergies access to information about products that contain known allergens. The company also provides Coppertone MyUVAlert that helps people avoid overexposure to the sun; and iManage Migraine, an application that helps people to track and understand what triggers their migraine headaches. In addition, it offers care plan management, patient education, remote monitoring, relationship management, and integrated analytics solutions. Preventice Inc. was formerly known as Boost Information Systems, Inc. The company was founded in 2007 and is based in Rochester, Minnesota with additional offices in Fargo, North Dakota.

Healthsense

Venture Round in 2014
Healthsense, Inc. specializes in remote monitoring services aimed at the senior care continuum. Founded in 2001 and based in Mendota Heights, Minnesota, the company provides health and safety monitoring solutions that track essential daily activities such as eating, sleeping, and movement. Their technology includes analytics that transform data into actionable insights, a centralized dashboard for caregivers, health notes to alert changes in behavior, and real-time notifications for urgent needs. These features help caregivers respond effectively to the needs of seniors, enhancing their independence and overall quality of life. Healthsense serves various markets, including senior living, managed care, and home care, and operates as a subsidiary of GreatCall, Inc. since December 2016.

Cleveland HeartLab

Venture Round in 2014
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.

medCPU

Series B in 2014
medCPU, Inc. delivers real-time clinical care advice through its Advisor Button technology for hospitals in the United States. Its Advisor Button captures the clinical picture from clinicians’ free-text notes, dictations, and structured documentation entered into EMR and analyzes it against a growing library of content for generating real-time precise prompts for care consideration; medCPU platform captures the clinical picture in real time, including narrative text and structured data to deliver the clinical and compliance guidance

ClearDATA

Series B in 2013
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Humedica

Funding Round in 2013
Humedica is the clinical intelligence company that powers health care providers and life sciences organ izations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.

Prognos

Series B in 2013
Prognos is a healthcare AI company dedicated to improving disease management through early intervention in collaboration with payers, life sciences, and diagnostics companies. It operates the Prognos Registry, which is the largest repository of clinical diagnostics information, encompassing over 5 billion medical records across more than 30 disease areas and covering 100 million patients. The company has developed 500 proprietary clinical algorithms that facilitate the early identification of patients, thereby enhancing treatment decision-making and risk management. Its platform, prognosFACTOR, efficiently analyzes vast amounts of lab and health records from over 325 million de-identified patients, providing rapid answers to clinically-focused healthcare inquiries. Prognos offers HIPAA-compliant healthcare data through its Prognos Marketplace, catering to various applications such as cohort design and health outcomes analysis, with a client base that includes a significant number of leading pharmaceutical manufacturers and payers.

eHealth Technologies™

Series D in 2013
eHealth Technologies™ (formerly eHealth Global) is a healthcare digital services company focused on retrieving, digitizing, storing, securing, and providing access to patient medical records. eHealth Technologies™ utilizes a processes to retrieve, secure, store, transmit, and present patient data to healthcare providers.

Healthsense

Venture Round in 2013
Healthsense, Inc. specializes in remote monitoring services aimed at the senior care continuum. Founded in 2001 and based in Mendota Heights, Minnesota, the company provides health and safety monitoring solutions that track essential daily activities such as eating, sleeping, and movement. Their technology includes analytics that transform data into actionable insights, a centralized dashboard for caregivers, health notes to alert changes in behavior, and real-time notifications for urgent needs. These features help caregivers respond effectively to the needs of seniors, enhancing their independence and overall quality of life. Healthsense serves various markets, including senior living, managed care, and home care, and operates as a subsidiary of GreatCall, Inc. since December 2016.

Healthsense

Series D in 2012
Healthsense, Inc. specializes in remote monitoring services aimed at the senior care continuum. Founded in 2001 and based in Mendota Heights, Minnesota, the company provides health and safety monitoring solutions that track essential daily activities such as eating, sleeping, and movement. Their technology includes analytics that transform data into actionable insights, a centralized dashboard for caregivers, health notes to alert changes in behavior, and real-time notifications for urgent needs. These features help caregivers respond effectively to the needs of seniors, enhancing their independence and overall quality of life. Healthsense serves various markets, including senior living, managed care, and home care, and operates as a subsidiary of GreatCall, Inc. since December 2016.

Rock Health

Venture Round in 2012
Rock Health is a venture capital firm based in San Francisco, California, that specializes in investing in early-stage digital health startups. Founded in 2010, the firm focuses on supporting entrepreneurs who are developing innovative solutions at the intersection of healthcare and technology. It provides funding, access to a network of venture and corporate partners, legal support, and office space to its portfolio companies. Rock Health aims to invest in companies that create health-oriented products, such as activity-tracking devices, telemedicine applications, and data analytics tools that improve healthcare outcomes and reduce costs. Its notable portfolio includes startups like Omada Health, Collective Health, and Doctor on Demand, which are dedicated to enhancing healthcare accessibility and effectiveness. The firm typically considers investments ranging from $0.1 to $0.25 million per company.

mihealth

Venture Round in 2012
Mihealth Global Systems, Inc. is a Toronto-based company that develops a healthcare messaging system designed to facilitate bi-directional communication between patients and physicians. Founded in 2009 by Dr. Wendy Graham, the mihealth application provides patients with secure online access to their physician-validated health information, enabling them to manage and organize their health data effectively. This interactive mobile technology enhances communication and allows physicians to stay updated on their patients' medical histories. By simplifying the connection between patients and healthcare providers, mihealth empowers individuals to take control of their health and wellness through accessible and user-friendly tools available on smartphones and tablets.

Aptus Health

Venture Round in 2012
Aptus Health provides digital health engagement solutions for healthcare providers and patients. Aptus Health is on a mission to dynamically connect health and life sciences companies with healthcare professionals, healthcare consumers, and other members of the healthcare ecosystem.

Daktari Diagnostics

Series B in 2011
Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

Preventice

Venture Round in 2011
Preventice Inc. develops mobile health applications and patient monitoring systems that connect mobile, home-based, and on-premise technologies for continuous patient care. It offers HealthClips Rx, an interactive patient education platform that feeds data about patient compliance and post-surgical complications back into the clinical system; and CARD-Contact Allergen Replacement Database, which provides people with skin allergies access to information about products that contain known allergens. The company also provides Coppertone MyUVAlert that helps people avoid overexposure to the sun; and iManage Migraine, an application that helps people to track and understand what triggers their migraine headaches. In addition, it offers care plan management, patient education, remote monitoring, relationship management, and integrated analytics solutions. Preventice Inc. was formerly known as Boost Information Systems, Inc. The company was founded in 2007 and is based in Rochester, Minnesota with additional offices in Fargo, North Dakota.

Medco Containment Services Inc.

Acquisition in 1993
Medco Containment Services Inc., one of the largest mail-order pharmacy and managed-care drug companies.